Adalimumab is a recombinant human anti-TNF monoclonal antibody used in the treatment of various immune-mediated diseases such as psoriatic arthritis, rheumatoid arthritis, and Crohn’s disease [3]. The gene discussed is TNF; the disease is psoriatic arthritis.